Ehrlich H P, Desmoulière A, Diegelmann R F, Cohen I K, Compton C C, Garner W L, Kapanci Y, Gabbiani G
Department of Surgery, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Am J Pathol. 1994 Jul;145(1):105-13.
There are two types of excessive scarring, keloid and hypertrophic scar. Contrary to hypertrophic scars, keloids do not regress with time, are difficult to revise surgically, and do not provoke scar contractures. These two lesions require different therapeutic approaches but are often confused because of an apparent lack of morphological differences. We have investigated the collagen organization and the possible presence of alpha-smooth muscle (SM) actin-expressing myofibroblasts in these conditions. Keloids contain large, thick collagen fibers composed of numerous fibrils closely packed together. In contrast hypertrophic scars exhibit modular structures in which fibroblastic cells, small vessels, and fine, randomly organized collagen fibers are present. We confirm that such nodular structures are always present in hypertrophic scar and rarely in keloid. Furthermore, only nodules of hypertrophic scars contain alpha-SM actin-expressing myofibroblasts. Electron microscopic examination supports the above-mentioned differences in collagen organization and in fibroblastic features and shows the presence of an amorphous extracellular material surrounding fibroblastic cells in keloid. The presence in hypertrophic scar myofibroblasts of alpha-SM actin, the actin isoform typical of vascular SM cells, may represent an important element in the pathogenesis of contraction. Interestingly, when placed in culture fibroblasts from hypertrophic scars and keloid express similar amounts of alpha-SM actin, suggesting that local microenvironmental factors influence in vivo the expression of this protein. Thus several morphological and immunohistochemical differences exist between hypertrophic scar and keloid that are useful for the biological and pathological characterization of the two lesions.
瘢痕过度增生有两种类型,即瘢痕疙瘩和增生性瘢痕。与增生性瘢痕不同,瘢痕疙瘩不会随时间消退,手术矫正困难,也不会引起瘢痕挛缩。这两种病变需要不同的治疗方法,但由于明显缺乏形态学差异,它们常常被混淆。我们研究了在这些情况下的胶原组织以及可能存在的表达α - 平滑肌(SM)肌动蛋白的肌成纤维细胞。瘢痕疙瘩含有由紧密排列在一起的大量原纤维组成的粗大胶原纤维。相比之下,增生性瘢痕呈现出模块化结构,其中存在成纤维细胞、小血管以及细小的、随机排列的胶原纤维。我们证实这种结节状结构在增生性瘢痕中总是存在,而在瘢痕疙瘩中很少见。此外,只有增生性瘢痕的结节含有表达α - SM肌动蛋白的肌成纤维细胞。电子显微镜检查支持了上述胶原组织和成纤维细胞特征方面的差异,并显示瘢痕疙瘩中成纤维细胞周围存在无定形细胞外物质。增生性瘢痕肌成纤维细胞中存在α - SM肌动蛋白,这是血管平滑肌细胞典型的肌动蛋白异构体,可能是收缩发病机制中的一个重要因素。有趣的是,当置于培养中时来自增生性瘢痕和瘢痕疙瘩的成纤维细胞表达相似量的α - SM肌动蛋白,这表明局部微环境因素在体内影响该蛋白的表达。因此,增生性瘢痕和瘢痕疙瘩之间存在几种形态学和免疫组织化学差异,这些差异有助于对这两种病变进行生物学和病理学特征描述。